triple hormone receptor agonist retatrutide Dr. Rutman | Weight Loss | Aesthetics | Regenerative Dual and Triple Gut Peptide

In other words, to prevent muscle loss from GLP-1 drugs eat nutritious, whole-foods, and include protein-rich options, while avoiding processed added-sugar foods

Despite GLP-1s being indicated for diabetes, obesity and some heart conditions, the Bridge program will almost solely be available to beneficiaries seeking weight management solutions

Wegovy commonly causes nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation

Retatrutide is a Phase 3 investigational compound not yet approved by any regulatory agency as of June 2026

Flavor in fewer bites Following trials in the fall of 2025, US restaurant chain Olive Garden is introducing a new section for its 2026 menu, featuring smaller portions